The call will be simultaneously broadcast live over the Internet on vcall.com at http://www.investorcalendar.com/IC/CEPage.asp?ID=170281. A replay of the webcast will be available on Vcall for 90 days.
For further information, visit the Cantel website at www.cantelmedical.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.CANTEL MEDICAL CORP. CONDENSED CONSOLIDATED STATEMENTS OF INCOME(In thousands, except per share data)(unaudited)Three Months EndedOctober 31,20122011Net sales$
93,262Cost of sales55,95455,312Gross profit43,72737,950Expenses: Selling13,41312,923 General and administrative12,04812,102 Research and development2,2942,145Total operating expenses27,75527,170Income before interest and income taxes15,97210,780Interest expense6461,031Interest income(13)(30)Income before income taxes15,3399,779Income taxes5,7633,559Net income $
,220Earnings per common share - diluted$
.23Dividends per common share $
.05Weighted average shares - diluted 27,36126,899 CANTEL MEDICAL CORP.CONDENSED CONSOLIDATED BALANCE SHEETS(In thousands)(unaudited)October 31,July 31,20122012AssetsCurrent assets$
33,892Property and equipment,
|SOURCE Cantel Medical Corp.|
Copyright©2012 PR Newswire.
All rights reserved